UDIV:CA:TSX-Manulife Smart U.S. Dividend ETF Hedged (CAD)

ETF | Others |

Last Closing

CAD 13.63

Change

-0.07 (-0.51)%

Market Cap

CAD 0.11B

Volume

500.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 5.46B
XEQT:CA iShares Core Equity Portfolio

-0.14 (-0.42%)

CAD 5.15B
PHYS-U:CA Sprott Physical Gold Trust

+0.14 (+0.65%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.02 (-0.05%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.07 (-0.26%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.22 (-1.89%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.04 (+0.18%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

-0.16 (-0.32%)

CAD 2.59B

ETFs Containing UDIV:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.36% 46% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.36% 46% F 49% F
Trailing 12 Months  
Capital Gain 25.85% 62% D 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.85% 62% D 62% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.24% 53% F 44% F
Dividend Return 2.42% 53% F 39% F
Total Return 0.18% 67% D+ 19% F
Risk Return Profile  
Volatility (Standard Deviation) 8.35% 52% F 77% C+
Risk Adjusted Return 28.98% 50% F 48% F
Market Capitalization 0.11B 64% D 35% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.